Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 62.04
-1.46 (-2.30%)
At close: Oct 15, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 14.17 billion as of October 15, 2026. It is the 30,070th most valuable company in the world and the 143rd biggest in Pakistan. Its market cap has decreased by 34.74% in one year.
Market Cap
14.17B
Enterprise Value
16.93B
Revenue
14.08B
Global Rank
Country Rank
#143 Pakistan
PE Ratio
17.93
ChartMarket Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 14.17B, an increase of 98.38%. That is a compound annual growth rate of 13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 14.17B | -26.67% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 99.31B |
| Abbott Laboratories (Pakistan) | 91.44B |
| Highnoon Laboratories | 48.55B |
| The Searle Company | 46.08B |
| AGP Limited | 45.08B |
| Ferozsons Laboratories | 14.48B |
| Macter International | 11.32B |
| Otsuka Pakistan | 4.42B |